THE NEW PROSPECT FOR WEIGHT CONTROL ?

Scientists are increasingly focused on retatrutide, a promising medication from Eli Lilly, as a potential advance in weight management. Distinct from many existing approaches, retatrutide is a double -action compound targeting equally GLP-1 and GIP, chemicals that influence satiety and glucose b